[1]
“Pharmacogenomic Profiling of DPYD and UGT1A1 Variants and Prediction of Chemotherapy Toxicity in Patients with Advanced Colorectal Cancer: A Review”, AGDD, vol. 9, no. 1, pp. 32–36, Jul. 2026, doi: 10.5281/zenodo.22207570.